Aducanumab: A Deep Dive into BIIB037 and its Impact A drug, previously known as BIIB037, is a notable effort to combat emerging Alzheimer's disease. Developed by Biogen, aducanumab works by removing amyloid deposits https://violavhtm313152.blog5.net/93198968/text